Please sign in to follow a disease.
Tuberculosis
MONDO:0018076A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.
Also known as: tuberculosis disease, active tuberculosis, Kochs disease, TB
299 clinical trials for this condition and its sub-types, 218 tagged with Tuberculosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Tuberculosis
-
Pulmonary tuberculosis 108 trials · 111 incl. sub-types
3 sub-types
- Tuberculous fibrosis of lung 3 trials
- Primary pulmonary tuberculosis 0 trials
- Silicotuberculosis 0 trials
-
Latent tuberculosis infection 72 trials
-
Drug-resistant tuberculosis 9 trials · 40 incl. sub-types
4 sub-types
- Multidrug-resistant tuberculosis 36 trials
- Rifampicin-resistant tuberculosis 20 trials
- Extensively drug-resistant tuberculosis 5 trials
- Totally drug-resistant tuberculosis 0 trials
-
Extrapulmonary tuberculosis 6 trials · 28 incl. sub-types
13 sub-types
- Central nervous system tuberculosis 1 trial · 7 incl. sub-types Sub-types →
- Pleural tuberculosis 7 trials Sub-types →
- Urogenital tuberculosis 0 trials · 7 incl. sub-types Sub-types →
- Lymph node tuberculosis 3 trials
- Gastrointestinal tuberculosis 0 trials · 2 incl. sub-types Sub-types →
- Miliary tuberculosis 2 trials
- Pericardial tuberculosis 1 trial
- Abdominal tuberculosis 0 trials Sub-types →
- Cardiac tuberculosis 0 trials
- Cutaneous tuberculosis 0 trials Sub-types →
- Laryngeal tuberculosis 0 trials
- Ocular tuberculosis 0 trials
- Skeletal tuberculosis 0 trials Sub-types →
-
Active tuberculosis 23 trials
-
Tuberculous encephalopathy 1 trial
-
Endocrine tuberculosis 0 trials
1 sub-type
- Hepatic tuberculosis 0 trials
-
Multifocal tuberculosis 0 trials
-
Primary bone and joint tuberculosis 0 trials
-
Primary tuberculous lymphadenitis 0 trials
-
Tuberculoma 0 trials
Most studied deeper sub-types
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Stopped earlyThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a 3-Month TB cocktail replace the standard 6-Month regimen?
Disease control Stopped earlyThis clinical trial investigates whether a 3-month combination of clofazimine and rifapentine can effectively treat drug-susceptible tuberculosis (TB) compared to the standard 6-month regimen. The study includes adults with pulmonary TB, some of whom also have HIV. Researchers ar…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could aspirin or ibuprofen help beat TB faster?
Disease control Stopped earlyThis study tested whether adding aspirin or ibuprofen to standard tuberculosis (TB) treatment helps patients recover more quickly. It included 426 adults with drug-sensitive or drug-resistant TB. The trial was terminated early, so the results are not conclusive.
Phase 2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New TB drug cocktails aim to cut treatment time in half
Disease control Stopped earlyThis clinical trial tested whether combining several drugs—bedaquiline, OPC-167832, sutezolid, and either pretomanid or delamanid—could treat pulmonary tuberculosis in just 2 to 4 months instead of the standard 6 months. The study enrolled 93 adults with drug-sensitive or drug-re…
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
TB prevention study halted early – only 16 volunteers enrolled
Prevention Stopped earlyThis study aimed to see if a single dose of the BCG vaccine could prevent tuberculosis infection in healthy adults traveling to countries with high TB rates. Participants were randomly assigned to receive either BCG or a placebo. The study was terminated early and enrolled only 1…
Phase 3 • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Pregnancy drug study aims to protect moms and babies from HIV and TB
Knowledge-focused Stopped earlyThis study looked at how HIV and tuberculosis (TB) medications are processed in the bodies of pregnant women and new mothers. Researchers measured drug levels in the blood of 205 women during pregnancy and after delivery to see if standard doses are effective. The goal was to gat…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC